Anastassov George
Transaction: 11/14/2025
BUY
Change
+1,686,956
Price
Not reported
Filing
11/14/2025
Type
BUY
Incannex Healthcare Limited
IXHL • Biotechnology
$0.00
— 0.00 (0.00%)
EarningsLatest report: Mar 31, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$38.88M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.02Healthy liquidity · 2.86Negative growth trendWeak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 15, 2026, 12:00 AM UTCLast profile update: Sep 4, 2026, 12:14 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.00
Change0.00%
Market Cap$38.88M
52W Range2.49 - 20.31
Beta2.75
Gross Margin-186.05%
Oper. Margin-276.62%
Profit Margin-545.17%
Debt/Eq0.02
Current Ratio2.86
Quick Ratio2.86
Volume77.19K
Price$0.00
Change0.00%
Market Cap$38.88M
52W Range2.49 - 20.31
Beta2.75
Gross Margin-186.05%
Oper. Margin-276.62%
Profit Margin-545.17%
Debt/Eq0.02
Current Ratio2.86
Quick Ratio2.86
Volume77.19K
Avg Volume213.66K
EPS Surprise0.25
Investment DNA
How strong this company looks for long-term investors
38
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
70/100
Why this score▼
Manageable debt level · 0.02Healthy liquidity · 2.86Negative growth trendWeak profitability
Analyst view
No analyst data available now.
Insider Transactions
Recent executive and insider activity
Latham Joel
Transaction: 11/14/2025
BUY
Change
+22,608,692
Price
Not reported
Filing
11/14/2025
Type
BUY
Swan Joseph
Transaction: 11/14/2025
BUY
Change
+869,565
Price
Not reported
Filing
11/14/2025
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Anastassov George | BUY | +1,686,956 | Not reported | 11/14/2025 | 11/14/2025 |
| Latham Joel | BUY | +22,608,692 | Not reported | 11/14/2025 | 11/14/2025 |
| Swan Joseph | BUY | +869,565 | Not reported | 11/14/2025 | 11/14/2025 |
| Widdows Peter | BUY | +1,686,956 | Not reported | 11/14/2025 | 11/14/2025 |
| Clark Robert | BUY | +1,686,956 | Not reported | 11/14/2025 | 11/14/2025 |
| Valentine Troy | BUY | +11,302,608 | Not reported | 11/14/2025 | 11/14/2025 |
| Barbato Luigi M. | BUY | +100,476 | Not reported | 10/23/2024 | 10/24/2024 |
| Barbato Luigi M. | OTHER | 0 | Not reported | 10/21/2024 | 10/24/2024 |
| Swan Joseph | OTHER | 0 | Not reported | 06/30/2024 | 08/02/2024 |
| Clark Robert | BUY | +100,000 | Not reported | 12/21/2023 | 12/21/2023 |
| Anastassov George | BUY | +100,000 | Not reported | 12/21/2023 | 12/21/2023 |
| Latham Joel | BUY | +1,340,000 | Not reported | 12/21/2023 | 12/21/2023 |
| Widdows Peter | BUY | +100,000 | Not reported | 12/21/2023 | 12/21/2023 |
| Valentine Troy | BUY | +670,000 | Not reported | 12/21/2023 | 12/21/2023 |
| Clark Robert | SELL | -25,000 | $98.63 | 11/28/2023 | 12/08/2023 |
| Latham Joel | SELL | -9,334 | $17.10 | 11/28/2023 | 12/06/2023 |
| Latham Joel | SELL | 0 | Not reported | 11/28/2023 | 12/06/2023 |
| Swan Joseph | SELL | -1,000 | $20.39 | 11/28/2023 | 12/06/2023 |
| Swan Joseph | SELL | 0 | Not reported | 11/28/2023 | 12/06/2023 |
| Changoer Lekhram | OPTION | 0 | Not reported | 11/28/2023 | 12/06/2023 |